Cite
Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?
MLA
Goda, Jayant S., et al. “Impact of Oligodendroglial Component in Glioblastoma (GBM-O): Is the Outcome Favourable than Glioblastoma?” Clinical Neurology & Neurosurgery, vol. 135, Aug. 2015, pp. 46–53. EBSCOhost, https://doi.org/10.1016/j.clineuro.2015.05.005.
APA
Goda, J. S., Lewis, S., Agarwal, A., Epari, S., Churi, S., Padmavati, A., Gupta, T., Shetty, P., Moiyadi, A., & Jalali, R. (2015). Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma? Clinical Neurology & Neurosurgery, 135, 46–53. https://doi.org/10.1016/j.clineuro.2015.05.005
Chicago
Goda, Jayant S., Shirley Lewis, Aditi Agarwal, Sridhar Epari, Shraddha Churi, A. Padmavati, Tejpal Gupta, Prakash Shetty, Aliasgar Moiyadi, and Rakesh Jalali. 2015. “Impact of Oligodendroglial Component in Glioblastoma (GBM-O): Is the Outcome Favourable than Glioblastoma?” Clinical Neurology & Neurosurgery 135 (August): 46–53. doi:10.1016/j.clineuro.2015.05.005.